Pulse Biosciences Inc
NASDAQ:PLSE
Pulse Biosciences Inc
NASDAQ:PLSE
Price:
7.19 USD
7.47%
Updated:
Apr 29, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of PLSE.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PLSE
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
PLSE Competitors Multiples
Pulse Biosciences Inc Competitors
Pulse Biosciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Pulse Biosciences Inc
NASDAQ:PLSE
|
396.5m USD | 0 | -9.4 | -8.3 | -8.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
187B USD | 4.6 | 33.1 | 19.5 | 29 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 18.2 | 67 | 54.9 | 68.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129.1B USD | 6.2 | 40.3 | 25.1 | 31.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.7B USD | 7.5 | 68.3 | 31.7 | 47.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.5B USD | 3.3 | 25.2 | 13.5 | 19.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.6B USD | 3.4 | 54.9 | 18.4 | 38.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
60.1B EUR | 2.8 | 39.6 | 18.9 | 31.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.5B USD | 8.7 | 37 | 26.8 | 29 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
365.4B CNY | 10.6 | 32.2 | 28 | 28 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 13.2 | 88.5 | 59.6 | 77.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
